Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AI Ready and Equitable Atlas for Diabetes Insights

Enrolling by invitation
  • Type 2 Diabetes
    • Birmingham, Alabama
    • +2 more
    Aug 18, 2023

    Type 2 Diabetes, PreDiabetes, Obesity Trial in Birmingham (continuous glucose monitor (Freestyle Libre)

    Not yet recruiting
    • Type 2 Diabetes
    • +2 more
    • continuous glucose monitor (Freestyle Libre
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 31, 2023

    Type 2 Diabetes, T2D Trial in Worldwide (LY3209590, Insulin Glargine)

    Recruiting
    • Type 2 Diabetes
    • T2D
    • Birmingham, Alabama
    • +71 more
    Jan 26, 2023

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)

    Not yet recruiting
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +96 more
    Aug 8, 2022

    Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +60 more
    Jun 7, 2022

    Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Active, not recruiting
    • Type 2 Diabetes
    • +2 more
    • Birmingham, Alabama
    • +74 more
    Apr 18, 2022

    Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),

    Completed
    • Type 2 Diabetes
    • Comparative Effectiveness of Glycemia-lowering Medications
    • Sulfonylurea (glimepiride)
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Apr 13, 2022

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +126 more
    Jan 21, 2022

    Type 2 Diabetes Trial in United States (Rivoglitazone, Pioglitazone, Placebo)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +73 more
    May 6, 2021

    Type 2 Diabetes Trial in Worldwide (Placebo, Exenatide)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +52 more
    Nov 6, 2020

    Type 2 Diabetes Trial in Leicester, Birmingham (Liraglutide, Sulfonylurea or Pioglitazone, Maintain dual therapy (Sulf/Pio) as

    Completed
    • Type 2 Diabetes
    • Leicester, Leicestershire, United Kingdom
    • +1 more
    Jan 29, 2020

    Obesity, Type 2 Diabetes Trial in Birmingham (Dietary)

    Completed
    • Obesity
    • Type 2 Diabetes
    • Dietary
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 21, 2019

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    Has Results
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

    Terminated
    • Type 2 Diabetes
    • ITCA 650 (exenatide in DUROS)
    • Birmingham, Alabama
    • +50 more
    Mar 4, 2019

    Type 1 Diabetes, Type 2 Diabetes Trial in Birmingham (Exercise, Hyperglycemia)

    Withdrawn
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Exercise
    • Hyperglycemia
    • Birmingham, West Midlands, United Kingdom
      University of Birmingham
    May 15, 2018

    Type 2 Diabetes Trial in Puerto Rico, United States (INCB013739, Placebo comparator matching INCB013739, Metformin)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +67 more
    Feb 12, 2018

    Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +138 more
    Mar 29, 2017

    Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin glargine/lixisenatide (HOE901/AVE0010)
    • +2 more
    • Birmingham, Alabama
    • +235 more
    Mar 31, 2017

    Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Metformin XR)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +98 more
    Jan 5, 2017

    Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

    Terminated
    Has Results
    • Type 2 Diabetes
    • Obesity
    • EndoBarrier
    • Sham Procedure
    • Birmingham, Alabama
    • +24 more
    Dec 2, 2016

    Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +328 more
    Dec 2, 2016

    Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID)

    Completed
    Has Results
    • Type 2 Diabetes
    • Lixisenatide (AVE0010)
    • +4 more
    • Sun City, Arizona
    • +198 more
    Nov 4, 2016

    Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +297 more
    Nov 10, 2016

    Type 2 Diabetes Trial in Worldwide (dapagliflozin, , metformin)

    Completed
    • Type 2 Diabetes
    • Bayou La Batre, Alabama
    • +144 more
    Nov 16, 2016

    Type 2 Diabetes Trial in Worldwide (, exenatide)

    Completed
    Has Results
    • Type 2 Diabetes
    • Peoria, Arizona
    • +58 more
    Oct 21, 2016